XOR-mediated tumor-selective nanomaterial therapy: achieving tumor and immune cell dual regulation through intracellular ROS generation

The hereby-presented newly developed nanomaterial could serve as a promising novel tool for gastric cancer immunotherapy.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-02-14
DOI
https://doi.org/10.1186/s12951-026-04150-6
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

XOR-mediated tumor-selective nanomaterial therapy: achieving tumor and immune cell dual regulation through intracellular ROS generation

Bingjun Li, Chuxuan Liu, Luyu Li, Y. Zhang et al.
Journal of Nanobiotechnology
Nanoplatforms for cancer theranostics
article

XOR-mediated tumor-selective nanomaterial therapy: achieving tumor and immune cell dual regulation through intracellular ROS generation

Bingjun Li, Chuxuan Liu, Luyu Li, Y. Zhang, Xin Jin, Jiankang Zhu, Linchuan Li, Guangyong Zhang, Hongyu Zhang
article en

Abstract

The hereby-presented newly developed nanomaterial could serve as a promising novel tool for gastric cancer immunotherapy.

Journal of NanobiotechnologyVol. 24(1)
Shandong University of Traditional Chinese Medicine (CN), Shandong University (CN), Shandong Provincial QianFoShan Hospital (CN), Shandong First Medical University (CN)
Good health and well-being
Openalex Percentile: Top 56%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.